Lipscomb University Novel Coronavirus COVID-19 update and response.Learn More
Akers received his Pharm.D. from the University of Tennessee and his Ph.D. in Clinical Pharmaceutical Sciences at the University of Kentucky. While at the University of Kentucky, he was a faculty member in the Department of Pharmacy Practice and Science, served on graduate student advisory committees as full member of the Graduate Faculty, and coordinated the graduate program track in Clinical and Experimental Therapeutics in the Department of Pharmaceutical Sciences. His current academic teaching responsibilities includes drug metabolism, pharmacokinetics, pharmacogenomics, and drug delivery systems in the professional pharmacy program at Lipscomb University as well as the graduate pharmacology program at Vanderbilt University. Akers research expertise as a clinical pharmaceutical scientist bridges the pre-clinical and clinical phases of small molecule drug development in the areas of pre-formulation and formulation development, drug metabolism and drug transporter assessment, and modelling pharmacokinetic and pharmacodynamic response relationships in cell-based assays, isolated organs, whole animal models, and humans. Over the past 20 years, his research has focused on identifying factors that contribute to variability in drug response in support of numerous phase I and phase II clinical research projects. In his administrative role, Akers oversees the research operations and research training programs in the Pharmaceutical Sciences Research Center. He also serves as the co-director of the Pharm.D./Ph.D. degree partnership program between the department of pharmaceutical sciences at Lipscomb University and the department of pharmacology at Vanderbilt University. In this role, he serves as a member of the student’s graduate research committee to help ensure that the depth and breadth of their training experiences continues to progress in terms of developing their scientific expertise while maintaining their clinical and professional skill sets.